| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.11 | 0.08 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.063 | 0.3 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.068 | 0.3 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.066 | 0.3 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.052 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.037 | 0.5 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.028 | 0.6 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.026 | 0.6 |